EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study

Nauryzbay Imanbayev, Yerbolat Iztleuov, Arip Koyshybaev, Aigul Zhumasheva, Beibit Baizakov, Nurgul Kereyeva, Zhanna Satenova, Aigerim Imanbayeva, Anara Tulyayeva, Dinara Zholmukhamedova, Marzhan Aitmagambetova, Azamat Zharylgapov

Medicinski Glasnik · 2025

DOI: 10.17392/1848-22-02 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Medicinski Glasnik, 2025. Verfasst von Nauryzbay Imanbayev und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of oncology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Antigens, CD. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

<p><strong>Aim.</strong> Colorectal cancer (CRC) ranks among the leading causes of cancer-related mortality worldwide, with significant incidence and mortality rates recorded in Kazakhstan. CRC poses a substantial healthcare burden, prompting investigations into novel prognostic markers.</p> <p><strong>Aim.</strong> This study investigates the prognostic significance of CD163 expression in patients with colorectal cancer.</p> <p><strong>Methods.</strong> This retrospective cohort study was conducted in Aktobe, Kazakhstan, utilizing tissue microarrays from 175 patients diagnosed with Tumor, Node, Metastasis (TNM) stage I&ndash;IV colon adenocarcinoma. CD163 expression was assessed through immunohistochemistry. Kaplan-Meier survival analysis was employed to estimate 5-year overall survival, defined as the interval from diagnosis to death or last follow-up. Cox proportional hazards models were used to evaluate the relationship between CD163 expression levels and survival outcomes.</p> <p><strong>Results.</strong> High CD163 expression was linked to advanced disease stage of colorectal cancer (p &lt; 0.001), lymphovascular invasion (p &lt; 0.001), perineural invasion (p &lt; 0.001), and Collagen I&gt;30%, A type (p&lt;0.001). CD163 infiltration was a negative prognostic factor for colorectal cancer patients, with higher risks of death in the high CD163 expression group compared to the low CD163 group (HR=5.769, 95% CI 3.194 &ndash; 10.42, p&lt;0.001).</p> <p><strong>Conclusion.</strong> The findings highlight CD163 as a potential prognostic biomarker in CRC, warranting further investigation into its mechanistic role and therapeutic implications.</p>

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAntigens, Differentiation, MyelomonocyticReceptors, Cell SurfaceAntigens, CDAdenocarcinomaHumansCD163 AntigenMaleRetrospective StudiesFemaleMiddle AgedPrognosisBiomarkers, TumorAgedAdultNeoplasm StagingKaplan-Meier EstimateProportional Hazards ModelsImmunohistochemistry

Stichwörter der Autor:innen

adenocarcinomabiomarkers tumorimmunohistochemistrysurvival analysistumor microenvironment

Substanzen

CD163 AntigenAntigens, Differentiation, MyelomonocyticReceptors, Cell SurfaceAntigens, CDBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of oncology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan.
  • Department of Radiology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan.
  • Department of Oncology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan.
  • Medical Centre, 4. Department of Pathomorphology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan.
  • Medical Centre, 8. Department of Pathomorphology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan.

Zitieren

APA

Imanbayev, N., Iztleuov, Y., Koyshybaev, A., Zhumasheva, A., Baizakov, B., Kereyeva, N., Satenova, Z., Imanbayeva, A., Tulyayeva, A., Zholmukhamedova, D., Aitmagambetova, M., & Zharylgapov, A. (2025). Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study. Medicinski Glasnik. https://doi.org/10.17392/1848-22-02

Vancouver

Imanbayev N, Iztleuov Y, Koyshybaev A, Zhumasheva A, Baizakov B, Kereyeva N, et al. Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study. Medicinski Glasnik. 2025. doi:10.17392/1848-22-02

BibTeX
@article{Imanbayev2025,
  author = {Imanbayev, Nauryzbay and Iztleuov, Yerbolat and Koyshybaev, Arip and Zhumasheva, Aigul and Baizakov, Beibit and Kereyeva, Nurgul and Satenova, Zhanna and Imanbayeva, Aigerim and Tulyayeva, Anara and Zholmukhamedova, Dinara and Aitmagambetova, Marzhan and Zharylgapov, Azamat},
  title = {Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study},
  journal = {Medicinski Glasnik},
  year = {2025},
  doi = {10.17392/1848-22-02}
}
Kostenlos starten →